Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association Between Genetically Proxied SLC12A2 Inhibition and Inflammatory Bowel Disease: A Mendelian Randomization Study.

Biochemical genetics - 1 Feb 2026

Yu Xin, Cao Yongsheng, Mao Changkun, Tao Chengpin, Chen Wei

Abstract excerpt

The global rise in hypertension prompts the use of medications to manage blood pressure. However, selecting first-line drugs remains challenging as their efficacy often stems from blood pressure reduction rather than specific pharmacological actions. Evaluating interactions between antihypertensive drugs and common diseases can aid tailored treatment. Here, we assess the potential link between antihypertensives...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Caco-2 Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ACE gene

Share to Genome-Wide Association Study

Share to Inflammatory Bowel Diseases

Share to Mendelian Randomization Analysis

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 39913044
DOI: 10.1007/s10528-025-11037-y

Genes

SLC12A2
ACE
NR3C1
SCNN1D
SLC16A1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association Between Genetically Proxied SLC12A2 Inhibition and Inflammatory Bowel Disease: A Mendelian Randomization Study.PMID 39913044Read ↗

Association between genetically proxied SLC12A2 inhibition and inflammatory bowel disease: A Mendelian randomization studySemantic proximity Read ↗

Identification of potential novel targets for treating inflammatory bowel disease using Mendelian randomization analysis.Semantic proximity Read ↗

Exploring inflammatory bowel disease therapy targets through druggability genes: a Mendelian randomization study.Semantic proximity Read ↗

Assessing the impact of blood pressure in the development of inflammatory bowel disease.Semantic proximity Read ↗

Causal relationship between inflammatory factors and inflammatory bowel disease: A bidirectional Mendelian randomization study combined with meta-analysis.Semantic proximity Read ↗

Identification of Novel Drug Target Genes in Inflammatory Bowel Disease through Mendelian Randomization Study and Single-Cell AnalysisSemantic proximity Read ↗

Inflammatory bowel disease and diabetic nephropathy risk: a two-sample Mendelian randomization analysisSemantic proximity Read ↗

Genome-wide Mendelian randomization and multi-omics integration identify drug targets for irritable bowel syndromeSemantic proximity Read ↗

Does inflammatory bowel disease promote kidney diseases: a mendelian randomization study with populations of European ancestrySemantic proximity Read ↗

Causal relationship between blood metabolites and inflammatory bowel disease: a metabolome-wide mendelian randomization studySemantic proximity Read ↗

Inflammatory bowel disease increases the levels of albuminuria and the risk of urolithiasis: a two-sample Mendelian randomization studySemantic proximity Read ↗

Causal linkage between type 2 diabetes mellitus and inflammatory bowel disease: an integrated Mendelian randomization study and bioinformatics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.